Name: E[c(RGDfK)]c(RGDfK)
SKU: LS-3980
Availability: InStock

Grouped product items

Cantidad

Unidad de venta

Precio

Unidad de almacenamiento de stock (SKU)

Disponibilidad

A petición

LS-3980.0000

description

This cyclic RGD peptide shows high tumor targeting properties. It is an integrin inhibitor and gained interest non-small-cell lung cancer treatment. It can be easily conjugated to dyes (see for example LS 3950: ICG-E[c(RGDfK)]2), drug molecules, or chelators, like DOTA and NOTA.

references

1. Tumor targeting with radiolabeled alpha(v)beta(3) integrin binding peptides in a nude mouse model. Marcel L. Janssen, Wim J. Oyen, Ingrid Dijkgraaf, Leon F. Massuger, Cathelijne Frielink, D. Scott Edwards, Milind Rajopadhye, Henk Boonstra, Frans H. Corstens and Otto C. Boerman; Cancer Res. 2002; 62(21): 6146-6151.

2. microPET imaging of glioma integrin {alpha}v{beta}3 expression using (64)Cu-labeled tetrameric RGD peptide. Yun Wu, Xianzhong Zhang, Zhengming Xiong, Zhen Cheng, Darrell R. Fisher, Shuang Liu, Sanjiv S. Gambhir, and Xiaoyuan Chen; J. Nucl. Med. 2005; 46(10): 1707-1718.

References for similar peptides:

1. Radiolabeled Cyclic RGD Peptides as Radiotracers for Imaging Tumors and Thrombosis by SPECT. Yang Zhou, Sudipta Chakraborty, and Shuang Liu;

Theranostics 2011; 1: 58–82.

2. Jytte Oxboel et al., Comparison of two new angiogenesis PET tracers 68Ga-NODAGA-E[c(RGDyK)]2 and 64Cu-NODAGA-E[c(RGDyK)]2; in vivo imaging studies in human xenograft tumors, Comparison of two new angiogenesis PET tracers 68Ga-NODAGA-E[c(RGDyK)]2 and (64)Cu-NODAGA-E[c(RGDyK)]2; in vivo imaging studies in human xenograft tumors. Jytte Oxboela, Malene Brandt-Larsen, Christina Schjoeth-Eskesen, Rebecca Myschetzky, Henrik H. El-Ali, Jacob Madsen, Andreas Kjaer; Nuclear Medicine and Biology 2014; 41(3): 259-267.

DOI: 10.1016/j.nucmedbio.2013.12.003.

3. Stability Analysis of Glutamic Acid Linked Peptides Coupled to NOTA through Different Chemical Linkages. Lixin Lang, Ying Ma, Dale O. Kiesewetter, and Xiaoyuan Chen; Mol. Pharm. 2014; 11(11): 3867–3874. DOI: 10.1021/mp400706q.

* Disclaimer

We refer to our general terms and conditions.
All information contained in our webshop is compiled to the best of our knowledge.
Prices and product availability are subject to change and require reconfirmation. Please contact us for further information.